Aspirin in the Prevention of Colorectal Cancer
Authors: Harinder S. Garewal
Journal: Annals of Internal Medicine (1994)

Editorials15 August 1994Aspirin in the Prevention of Colorectal CancerHarinder S. Garewal, MD, PhDHarinder S. Garewal, MD, PhDVeterans Affairs Medical Center, Tucson, AZ 85723Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-121-4-199408150-00013 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail In 1993, there were approximately 152 000 new cases of and 57 000 deaths from colorectal cancer, making this disease one of the most prevalent and lethal malignancies in the United States [1]. A person older than 50 years has about a 5% chance of developing colorectal cancer and a 2.5% chance of dying of the disease. Although slightly more common in men, it is a major health risk for both sexes. Early lesions have an excellent cure rate, but advanced, metastatic disease remains incurable. Thus, the most promising approaches to decreasing the morbidity and mortality from colorectal cancer lie ...References1. Boring CC, Squires TS, Tong T. Cancer Statistics, 1993. CA Cancer J Clin. 1993; 43:7-26. Google Scholar2. Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med. 1993; 328:1365-71. Google Scholar3. Selby JV, Friedman GD, Quesenberry CP Jr, Weiss NS. A case–control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med. 1992; 326:653-7. Google Scholar4. Winawer SJ, Zauber AG, Ho MN, O'Brien MJ, Gottlieb LS, Sternberg SS, et al. Prevention of colorectal cancer by colonscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med. 1993; 329:1977-81. Google Scholar5. Lieberman D. Colon cancer screening: beyond efficacy (Editorial). Gastroenterology. 1994; 106:803-7. Google Scholar6. Trock B, Lanza E, Greenwald P. Dietary fiber, vegetables and colon cancer: critical review and meta-analysis of the epidemiologic evidence. J Natl Cancer Inst. 1990; 82:650-61. Google Scholar7. Thun MJ, Calle EE, Namboodiri MN, Flanders WD, Coates RJ, Byers T, et al. Risk factors for fatal colon cancer in a large prospective study. J Natl Cancer Inst. 1992; 84:1491-500. Google Scholar8. Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Ascherio A, Willett WC. Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann Intern Med. 1994; 121:241-6. Google Scholar9. Reddy BS, Maruyama H, Kelloff G. Dose-related inhibition of colon carcinogenesis by dietary piroxicam, a nonsteroidal antiinflammatory drug, during different stages of rat colon tumor development. Cancer Res. 1987; 47:5340-6. Google Scholar10. Pollard M, Luckert PH. Effect of piroxicam on primary intestinal tumors induced in rats by N-methylnitrosourea. Cancer Lett. 1984; 25:117-21. Google Scholar11. Waddell WR, Ganser GF, Cerise EJ, Loughry RW. Sulindac for polyposis of the colon. Am J Surg. 1989; 157:175-9. Google Scholar12. Giardiello FM, Hamilton SR, Krush AJ, Piantadosi S, Hylind LM, Celano P, et al. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med. 1993; 328:1313-6. Google Scholar13. Labeling revisions for NSAIDS. FDA Drug Bill. 1989; 19:3-4. Google Scholar14. Clive DM, Stoff JS. Renal syndromes associated with nonsteroidal antiinflammatory drugs. N Engl J Med. 1984; 310:563-72. Google Scholar15. Trujillo MA, Garewal HS, Sampliner RE. Nonsteroidal anti-inflammatory agents in the chemoprevention of colorectal cancer: at what cost? Dig Dis Sci. 1994; (In press). Google Scholar16. Dalen JE, Hirsh J. Antithrombotic Therapy. Introduction. Third ACCP Consensus Conference on Antithrombotic Therapy. Chest. 1992; 102:303s-4s. Google Scholar17. Kune GA, Kune S, Watson LF. Colorectal cancer risk, chronic illnesses, operations and medications: case control results from the Melbourne Colorectal Cancer Study. Cancer. 1988; 48:4399-404. Google Scholar18. Rosenberg L, Palmer JR, Zauber AG, Warshauer ME, Stolley PD, Shapiro S. A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer. J Natl Cancer Inst. 1991; 83:355-8. Google Scholar19. Thun MJ, Namboodiri MM, Heath CW Jr. Aspirin use and reduced risk of fatal colon cancer. N Engl J Med. 1991; 325:1593-6. Google Scholar20. Suh O, Mettlin C, Petrelli NJ. Aspirin use, cancer, and polyps of the large bowel. Cancer. 1993; 72:1171-7. Google Scholar21. Peleg II, Maibach HT, Brown SH, Wilcox CM. Aspirin and nonsteroidal anti-inflammatory drug use and the risk of subsequent colorectal cancer. Arch Intern Med. 1994; 154:394-9. Google Scholar22. Schreinemachers DM, Everson RB. Aspirin use and lung, colon, and breast cancer incidence in a prospective study. Epidemiology. 1994; 5:138-46. Google Scholar23. Paganini-Hill A, Chao A, Ross RK, Henderson BE. Aspirin use and chronic diseases: a cohort study of the elderly. BMJ. 1989; 299:1247-50. Google Scholar24. Gann PH, Manson JE, Glynn RJ, Buring JE, Hennekens CH. Low-dose aspirin and incidence of colorectal tumors in a randomized trial. J Natl Cancer Inst. 1993; 85:1220-4. Google Scholar Author, Article, and Disclosure InformationAuthors: Harinder S. Garewal, MD, PhDAffiliations: Veterans Affairs Medical Center, Tucson, AZ 85723Corresponding Author: Harinder S. Garewal, MD, PhD, Professor of Medicine, Assistant Director, Cancer Prevention and Control, Section of Hematology-Oncology (111D), Veterans Affairs Medical Center, 3601 South 6th Avenue, Tucson, AZ 85723.Grant Support: In part by the Department of Veterans Affairs Cooperative Studies Program (study #380) and the National Cancer Institute grant PO1 CA41108-08. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoAspirin Use and the Risk for Colorectal Cancer and Adenoma in Male Health Professionals Edward Giovannucci , Eric B. Rimm , Meir J. Stampfer , Graham A. Colditz , Alberto Ascherio , and Walter C. Willett Metrics Cited bySynthesis and anaerobic biodegradation of indomethacin-conjugated cellulose ethers used for colon-specific drug deliveryCáncer colorrectal: circunstancias inductoras (etiología) y caminos de realización (patogenia)Chemoprevention of Human Cancer:A Reasonable Strategy?Benign Colorectal Polyps: Endoscopic Surveillance Guidelines and Effects on Colorectal Cancer RiskMortality in rheumatoid arthritisEffect of sulindac on sporadic colonic polypsScreening for Colorectal CancerAspirin, age, and proximity to lymphoid nodules influence cell proliferation parameters in rat colonic crypts 15 August 1994Volume 121, Issue 4Page: 303-304KeywordsAdenomasAspirinCancer preventionCardiovascular diseasesColonoscopyColorectal cancerDietMortalityNSAIDsToxicity ePublished: 15 August 2000 Issue Published: 15 August 1994 Copyright & PermissionsCopyright © 1994 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...